Exact Mass: 321.1689

Exact Mass Matches: 321.1689

Found 76 metabolites which its exact mass value is equals to given mass value 321.1689, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Gabexate

ethyl 4-[(6-carbamimidamidohexanoyl)oxy]benzoate

C16H23N3O4 (321.1688)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent D006401 - Hematologic Agents > D000925 - Anticoagulants C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

5-((1-Ethyl-4-piperidinyl)oxy)-9H-pyrrolo(2,3-b:5,4-c')dipyridine-6-carbonitrile

3-[(1-ethylpiperidin-4-yl)oxy]-5,8,10-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile

C18H19N5O (321.159)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

Impromidine

N-[3-(1H-imidazol-5-yl)propyl]-N-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine

C14H23N7S (321.1736)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D017442 - Histamine Agonists

   

1-Pentyl-3-(4-methoxybenzoyl)indole

(4-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone

C21H23NO2 (321.1729)


   
   

RCS-4

(4-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone

C21H23NO2 (321.1729)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D063385 - Cannabinoid Receptor Modulators D018377 - Neurotransmitter Agents > D063385 - Cannabinoid Receptor Modulators > D063386 - Cannabinoid Receptor Agonists

   

gabexate

gabexate

C16H23N3O4 (321.1688)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent D006401 - Hematologic Agents > D000925 - Anticoagulants C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

6-O-beta-D-glucopyranosyl-1,2,3-trideoxy-1-C-ethyl-beta-galactonojirimycin

6-O-beta-D-glucopyranosyl-1,2,3-trideoxy-1-C-ethyl-beta-galactonojirimycin

C14H27NO7 (321.1787)


   

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-N-methylbenzamide

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-N-methylbenzamide

C21H23NO2 (321.1729)


   

Pleiocarpamine

Pleiocarpamine

C21H23NO2 (321.1729)


   

Isolobelanine

Isolobelanine

C21H23NO2 (321.1729)


   

RCS-4 3-Methoxy isomer

RCS-4 3-Methoxy isomer

C21H23NO2 (321.1729)


   

H-GLY-VAL-PHE-OH

H-GLY-VAL-PHE-OH

C16H23N3O4 (321.1688)


   
   
   
   
   
   
   

Carboxyterbinafine

(E)-2,2-dimethyl-7-[methyl(naphthalen-1-ylmethyl)amino]hept-5-en-3-ynoic acid

C21H23NO2 (321.1729)


   

RCS-4 2-methoxy isomer

RCS-4 2-methoxy isomer

C21H23NO2 (321.1729)


   

Arginine glutamate

L-Arginine L-glutamate

C11H23N5O6 (321.1648)


A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05B - Liver therapy, lipotropics > A05BA - Liver therapy L-Arginine L-glutamate ((S)-(+)-Arginine L-glutamate) is the nitrogen donor for synthesis of nitric oxide. L-Arginine L-glutamate can be used for upper gastrointestinal hypofunction or dysfunction like functional dyspepsia research[1]. L-Arginine L-glutamate ((S)-(+)-Arginine L-glutamate) is the nitrogen donor for synthesis of nitric oxide. L-Arginine L-glutamate can be used for upper gastrointestinal hypofunction or dysfunction like functional dyspepsia research[1].

   
   

1-boc-4-(carboxy-pyridin-4-yl-methyl)-piperazine

1-boc-4-(carboxy-pyridin-4-yl-methyl)-piperazine

C16H23N3O4 (321.1688)


   

(3-BOC-AMINO-PIPERIDIN-1-YL)-THIOPHEN-3-YL-ACETICACID

(3-BOC-AMINO-PIPERIDIN-1-YL)-THIOPHEN-3-YL-ACETICACID

C16H23N3O4 (321.1688)


   

3-amino-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]benzoic acid

3-amino-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]benzoic acid

C16H23N3O4 (321.1688)


   

T6NJ &RBR&R

T6NJ &RBR&R

C23H20BN (321.1689)


   

2-[3-methyl-4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid

2-[3-methyl-4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid

C16H23N3O4 (321.1688)


   

6-[3-methyl-4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid

6-[3-methyl-4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid

C16H23N3O4 (321.1688)


   

1-(3-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine

1-(3-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine

C17H25BClNO2 (321.1667)


   

2-(4-BOC-PIPERAZINYL)-2-(3-PYRIDINYL)ACETIC ACID

2-(4-BOC-PIPERAZINYL)-2-(3-PYRIDINYL)ACETIC ACID

C16H23N3O4 (321.1688)


   

4-(5-CARBOXY-PYRIDIN-2-YL)-[1,4]DIAZEPANE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(5-CARBOXY-PYRIDIN-2-YL)-[1,4]DIAZEPANE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C16H23N3O4 (321.1688)


   

(3-BOC-AMINO-PIPERIDIN-1-YL)-THIOPHEN-2-YL-ACETICACID

(3-BOC-AMINO-PIPERIDIN-1-YL)-THIOPHEN-2-YL-ACETICACID

C16H23N3O4 (321.1688)


   

Tazofelone

5-[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]-1,3-thiazolidin-4-one

C18H27NO2S (321.1762)


C308 - Immunotherapeutic Agent > C574 - Immunosuppressant

   

TERT-BUTYL 4-(3-NITROBENZYL)PIPERAZINE-1-CARBOXYLATE

TERT-BUTYL 4-(3-NITROBENZYL)PIPERAZINE-1-CARBOXYLATE

C16H23N3O4 (321.1688)


   

3-AMINO-6-((DIBENZYLAMINO)METHYL)-1,2,4-TRIAZIN-5(2H)-ONE

3-AMINO-6-((DIBENZYLAMINO)METHYL)-1,2,4-TRIAZIN-5(2H)-ONE

C18H19N5O (321.159)


   

tert-butyl 4-(4-methylpiperazin-1-yl)-2-nitrobenzoate

tert-butyl 4-(4-methylpiperazin-1-yl)-2-nitrobenzoate

C16H23N3O4 (321.1688)


   

TERT-BUTYL4-(2-NITROPHENYLAMINO)PIPERIDINE-1-CARBOXYLATE

TERT-BUTYL4-(2-NITROPHENYLAMINO)PIPERIDINE-1-CARBOXYLATE

C16H23N3O4 (321.1688)


   

4-[1-(3-methoxy-4-nitrophenyl)piperidin-4-yl]morpholine

4-[1-(3-methoxy-4-nitrophenyl)piperidin-4-yl]morpholine

C16H23N3O4 (321.1688)


   

4-(3-carboxy-pyridin-2-yl)-[1,4]diazepane-1-carboxylic acid tert-butyl ester

4-(3-carboxy-pyridin-2-yl)-[1,4]diazepane-1-carboxylic acid tert-butyl ester

C16H23N3O4 (321.1688)


   

tert-Butyl (1-(2-nitrophenyl)piperidin-4-yl)carbamate

tert-Butyl (1-(2-nitrophenyl)piperidin-4-yl)carbamate

C16H23N3O4 (321.1688)


   

tert-butyl 4-(2-methyl-4-nitrophenyl)piperazine-1-carboxylate

tert-butyl 4-(2-methyl-4-nitrophenyl)piperazine-1-carboxylate

C16H23N3O4 (321.1688)


   

N-[5-(2-phenylethyl)-1,3,5-triazinan-2-ylidene]-1,3-benzoxazol-2-amine

N-[5-(2-phenylethyl)-1,3,5-triazinan-2-ylidene]-1,3-benzoxazol-2-amine

C18H19N5O (321.159)


   

L-Phenylalanyl-L-valylglycine

L-Phenylalanyl-L-valylglycine

C16H23N3O4 (321.1688)


   

3,6-Diacetyl-9-isoamylcarbazole

3,6-Diacetyl-9-isoamylcarbazole

C21H23NO2 (321.1729)


   

3,6-Diacetyl-9-n-amylcarbazole

3,6-Diacetyl-9-n-amylcarbazole

C21H23NO2 (321.1729)


   

[(2R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(7-methoxynaphthalen-1-yl)methanone

[(2R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(7-methoxynaphthalen-1-yl)methanone

C21H23NO2 (321.1729)


   

N-[4-([1,2,4]triazolo[4,3-b]pyridazin-6-yl)phenyl]cyclohexanecarboxamide

N-[4-([1,2,4]triazolo[4,3-b]pyridazin-6-yl)phenyl]cyclohexanecarboxamide

C18H19N5O (321.159)


   

(E)-2,2-dimethyl-7-[methyl(naphthalen-1-ylmethyl)amino]hept-5-en-3-ynoic acid

(E)-2,2-dimethyl-7-[methyl(naphthalen-1-ylmethyl)amino]hept-5-en-3-ynoic acid

C21H23NO2 (321.1729)


   

5-amino-1-(3,5-dimethylphenyl)-N-(phenylmethyl)-4-triazolecarboxamide

5-amino-1-(3,5-dimethylphenyl)-N-(phenylmethyl)-4-triazolecarboxamide

C18H19N5O (321.159)


   

methyl 2-[2-methyl-3-[(E)-2-(1-methylpyridin-1-ium-4-yl)ethenyl]indol-1-yl]acetate

methyl 2-[2-methyl-3-[(E)-2-(1-methylpyridin-1-ium-4-yl)ethenyl]indol-1-yl]acetate

C20H21N2O2+ (321.1603)


   

1,3-Bis[4-(dimethylamino)phenyl]-2,4-dioxylatocyclobutene-3,4-diylium

1,3-Bis[4-(dimethylamino)phenyl]-2,4-dioxylatocyclobutene-3,4-diylium

C20H21N2O2+ (321.1603)


   
   
   
   
   

(3S,4S)-4-[2-(2-methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one

(3S,4S)-4-[2-(2-methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one

C18H27NO2S (321.1762)


   

(3R,4R)-4-[2-(2-methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one

(3R,4R)-4-[2-(2-methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one

C18H27NO2S (321.1762)


   

4-[2-(2-Methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one

4-[2-(2-Methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one

C18H27NO2S (321.1762)


   

4-[(5-Methylpyrazolidin-3-YL)amino]-2-phenylphthalazin-1-one

4-[(5-Methylpyrazolidin-3-YL)amino]-2-phenylphthalazin-1-one

C18H19N5O (321.159)


   
   
   
   

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-4-methylpent-2-enamide

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-4-methylpent-2-enamide

C16H23N3O4 (321.1688)


   

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-4-methylpent-3-enamide

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-4-methylpent-3-enamide

C16H23N3O4 (321.1688)


   

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-4-methylpent-3-enamide

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-4-methylpent-3-enamide

C16H23N3O4 (321.1688)


   

(5r)-5,9,17,17-tetramethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1(12),2(6),7(11),9,13(18),19-hexaene

(5r)-5,9,17,17-tetramethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1(12),2(6),7(11),9,13(18),19-hexaene

C21H23NO2 (321.1729)


   

2-[(2r,6s)-6-(2-oxo-2-phenylethyl)piperidin-2-yl]-1-phenylethanone

2-[(2r,6s)-6-(2-oxo-2-phenylethyl)piperidin-2-yl]-1-phenylethanone

C21H23NO2 (321.1729)


   

5,9,17,17-tetramethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1(12),2(6),7(11),9,13(18),19-hexaene

5,9,17,17-tetramethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1(12),2(6),7(11),9,13(18),19-hexaene

C21H23NO2 (321.1729)


   

2-[6-(2-oxo-2-phenylethyl)piperidin-2-yl]-1-phenylethanone

2-[6-(2-oxo-2-phenylethyl)piperidin-2-yl]-1-phenylethanone

C21H23NO2 (321.1729)


   
   

methyl (11s,14s,16r,18s)-13-ethylidene-1-azapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraene-18-carboxylate

methyl (11s,14s,16r,18s)-13-ethylidene-1-azapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraene-18-carboxylate

C21H23NO2 (321.1729)


   

methyl (11s,13e,14s,16r,18s)-13-ethylidene-1-azapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraene-18-carboxylate

methyl (11s,13e,14s,16r,18s)-13-ethylidene-1-azapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraene-18-carboxylate

C21H23NO2 (321.1729)


   

(5s)-5,9,17,17-tetramethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1(12),2(6),7(11),9,13(18),19-hexaene

(5s)-5,9,17,17-tetramethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1(12),2(6),7(11),9,13(18),19-hexaene

C21H23NO2 (321.1729)


   

n-[2-(2,2-dimethylchromen-6-yl)ethyl]-n-methylbenzamide

n-[2-(2,2-dimethylchromen-6-yl)ethyl]-n-methylbenzamide

C21H23NO2 (321.1729)


   

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-4-methylpent-2-enamide

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-4-methylpent-2-enamide

C16H23N3O4 (321.1688)